1 PL Global Burden of Cardiovascular Disease 2 DZ Ethical Decisions in Cardiovascular Medicine 3 DZ Clinical Decision Making in Cardiology 4 RB Measurement and Improvement of Quality of Care: Relevance to Cardiovascular Clinical Practice 5 DM Critical Evaluation of Clinical Trials 6 PL Personalized and Precision Cardiovascular Medicine 7 PL Principles of Cardiovascular Genetics 8 DZ Drug Therapeutics and Personalized Medicine 9 PL Biomarkers and Their Use in Precision Medicine 10 PL The History and Physical Examination: An Evidence-Based Approach 11 PL Evaluation and Management of the Noncardiac Surgical Patient- 12 DZ Electrocardiography 13 RB Exercise Testing 14 RB Echocardiography Appropriate Use Criteria: Echocardiography 15 RB The Chest Radiograph in Cardiovascular Disease 16 RB Nuclear Cardiology 17 Cardiovascular Magnetic Resonance 18 Cardiac Computed Tomography Appopriate Use Criteria: Multimodality Imaging in Stable Ischemic Heart Disease and Heart Failure 19 RB Cardiac Catheterization 20 Coronary Angiography and Intracoronary Imaging 21 DM Approach to the Patient With Heart Failure 22 DM Mechanisms of Cardiac Contraction and Relaxation 23 DM Pathophysiology of Heart Failure 24 DM Diagnosis and Management of Acute Heart Failure Guidelines: The Hospitalized Patient With Heart Failure 25 DM Management of Patients With Heart Failure With Reduced Ejection Fraction Guidelines: Management of Heart Failure with a Reduced Ejection Fraction 26 DM Heart Failure with a Preserved Ejection Fraction Guidelines: Heart Failure with a Preserved Ejection Fraction 27 DM Devices for Monitoring and Managing Heart Failure Guidelines: Cardiac Resynchronization Therapy and Implantable Cardioverter- Defibrillators for Heart Failure with a Reduced Ejection Fraction 28 DM Surgical Management of Heart Failure 29 DM Mechanical Circulatory Support 30 DM Cardiovascular Regeneration and Repair 31 DM Management of Patients with Advanced Heart Failure 32 DZ Approach to the Patient with Cardiac Arrhythmias 33 DZ Genetics of Cardiac Arrhythmias 34 DZ Mechanisms of Cardiac Arrhythmias 35 DZ Diagnosis of Cardiac Arrhythmias Guidelines: Ambulatory Electrocardiographic and Electrophysiological Testing 36 DZ General Therapy for Cardiac Arrhythmias 37 DZ Supraventricular Arrhythmias 38 DZ Atrial Fibrillation: Clinical Features, Mechanisms, and Management Guidelines: Atrial Fibrillation 39 DZ Ventricular Arrhythmias 40 DZ Bradycardia Arrhythmias 41 DZ Pacemakers and Implantable Cardioverter-Defibrillators Guidelines: Cardiac Pacemakers and Cardioverter-Defibrillators 42 DZ Cardiac Arrest and Sudden Cardiac Death 43 DZ Hypotension and Syncope Guidelines 44 PL The Vascular Biology of Atherosclerosis 45 PL Risk Markers and the Primary Prevention of Cardiovascular Disease 46 PL Systemic Hypertension: Mechanisms and Diagnosis 47 PL Systemic Hypertension: Management Guidelines: Treatment of Hypertension 48 PL Lipid Disorders and Cardiovascular Disease Guidelines: Management of Lipids 49 PL Nutrition and Cardiometabolic Diseases 50 Obesity and Cardiometabolic Disease 51 Diabetes and the Cardiovascular System Guidelines: Diabetes and Heart Disease 52 RB Environmental Exposures and CVD 53 PL Exercise and Sports Cardiology 54 PL Comprehensive Cardiac Rehabilitation 55 DZ Complementary Approaches to Heart Disease Management 56 PL Approach to the Patient with Chest Pain 57 RB Coronary Blood Flow and Myocardial Ischemia 58 PL ST-Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features 59 PL ST-Elevation Myocardial Infarction: Management Guidelines: Management of Patients with ST-Elevation Myocardial Infarction 60 PL Non-ST Elevation Acute Coronary Syndromes Guidelines: Unstable Angina and Non-ST Elevation Myocardial Infarction
Skalski J, Allison TG, Miller TD: The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases. Circulation 126:2465, 2012.
Sharma N, Howlett J. Current state of cardiac amyloidosis. ... Rutakingirwa M, Ziegler JL, Newton R, Freers J. Poverty and eosinophilia are risk factors for endomyocardial fibrosis ... Gallagher J, McDonald K, Ledwidge M, Watson CJ.
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
Benefit from the substantial experience of Elliott M. Antman, MD, Marc S. Sabatine, MD, and a host of other respected authorities, who provide practical, evidence-based rationales for all of today's clinical therapies.
The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders.
Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions.
This award-winning text has been completely updated, providing a superior multimedia reference for every aspect of this fast-changing field, including new material about almost every topic in cardiology"--Publisher's description.
... Mitral inflow ti c o l e 0 Adur ) s/ m ( 2.0 ∆E/A
Authoritative, portable, and up to date, Opie’s Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients.
Vogel RA, Corretti MC, Gellman J: Cholesterol, cholesterol lowering, and endothelial function. Prog Cardiovasc Dis 1998;41:117-136. 148. Vogel RA, Corretti MC, Plotnick GD: Effect of a single high-fat meal on endothelial function in ...